Adeia Inc. Logo

Adeia Inc.

Invents and licenses foundational IP for the media and semiconductor industries.

ADEA | NDAQ

Overview

Corporate Details

ISIN(s):
US98390M1036
LEI:
Country:
United States of America
Address:
3025 ORCHARD PARKWAY, 95134 SAN JOSE
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Adeia Inc. is a research and development (R&D) and intellectual property (IP) licensing company that invents, develops, and licenses foundational innovations for the media, entertainment, and semiconductor industries. The company's extensive patent portfolio in the media sector powers technologies for content search, discovery, and recommendation across over-the-top (OTT) streaming and pay-TV platforms. In the semiconductor space, Adeia provides foundational IP licenses. By offering access to its innovations, Adeia aims to accelerate the adoption of advanced technologies for its partners and customers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Adeia Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Adeia Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Adeia Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Model Solution Co., Ltd. Logo
One-stop prototyping & low-volume production for IT, electronics, and medical hardware.
South Korea 417970
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden MODTX
Moleculin Biotech, Inc. Logo
Developing therapies for hard-to-treat tumors (like AML) and viruses.
United States of America MBRX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland MOC
Moolec Science SA Logo
Uses Molecular Farming to grow animal proteins in plants for food, feed, and supplement industries.
United States of America MLEC
MoonLake Immunotherapeutics Logo
Developing Nanobody therapies for inflammatory and immunologic diseases like psoriatic arthritis.
United States of America MLTX
Mural Oncology plc Logo
Developing cytokine-based immunotherapies for difficult-to-treat cancers and solid tumors.
United States of America MURA
Mural Oncology PLC Logo
Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.
Ireland MURA
N2OFF, Inc. Logo
Sustainable agri-tech for food preservation, emissions reduction, and renewable energy.
United States of America NITO
NANO MRNA Co.,Ltd. Logo
Biotech IP generator developing and licensing mRNA therapeutics using proprietary delivery systems.
Japan 4571

Talk to a Data Expert

Have a question? We'll get back to you promptly.